Science and Research

Insmed: A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (INS1009-211)

A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

Study details
Study-ID: NCT05176951, 2021-003294-66
Study-ID: NCT05176951, 2021-003294-66
DZL Disease Area: PH
DZL Disease Area: PH
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL discovery-based, DZL recruiting center
DZL Role: DZL discovery-based, DZL recruiting center
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: CPC-M, TLRC, UGMLC
DZL Participating Sites: CPC-M, TLRC, UGMLC
Start Date: 01.11.2022
Completion Date: 31.03.2024
Status: Closed
Status: Closed
DZL discovery-based, DZL recruiting center
Link to Study


close
chevron-down

Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.